Skip to content
XLXLXL202020

Drawing based on the description in the official product monograph. No photo yet.

“20 mg tablets are yellow film-coated, round shaped with no score, debossed with "XL" on one side and "20" on the other side of the tablet; available in bottles of 30 tablets”

XL 20 pill

Pill with imprint XL 20 is yellow, round and has been identified as Cabozantinib Malate 20 mg. It is used for renal cell carcinoma. It is supplied by Ipsen Biopharmaceuticals Canada Inc.

Sold in Canada

Cabozantinib Malate 20 mg

Brand
Cabometyx
Imprint
XL 20
Strength
20 mg
Used for
Renal cell carcinoma
Color
Yellow
Shape
Round
Form
Tablet
Manufacturer
Ipsen Biopharmaceuticals Canada Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02480824

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cabozantinib Malate pills and guides

What is Cabozantinib Malate used for?

Cabozantinib Malate is used for renal cell carcinoma.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Renal Cell Carcinoma

CABOMETYX is indicated for the treatment of patients with advanced renal cell carcinoma (RCC).

CABOMETYX, in combination with nivolumab, is indicated for the first-line treatment of patients with advanced RCC.

Hepatocellular Carcinoma

CABOMETYX is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.

Differentiated Thyroid Cancer

CABOMETYX is indicated for the treatment of adult and pediatric patients 12 years of age and older with locally advanced or metastatic differentiated thyroid cancer (DTC) that has progressed following prior VEGFR-targeted therapy and who are radioactive iodine-refractory or ineligible.

Neuroendocrine Tumors

CABOMETYX is indicated for the treatment of adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic neuroendocrine tumors (pNET).

CABOMETYX is indicated for the treatment of adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated extra-pancreatic neuroendocrine tumors (epNET).

From the FDA-approved label on DailyMed (published Nov 17, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows XL 20. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Cabometyx by Ipsen Biopharmaceuticals Canada Inc.

In Canada: prescription only.

Ingredients

Active: Cabozantinib (Cabozantinib Malate)

Other pills with imprint XL 20

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Cabozantinib Malate pills